Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1

Journal of General Virology

Volumn 77, Issue 7, 1996, Pages 1389-1395

  Ochsenbauer, Christina ^a   Bosch, Valerie ^a   Oelze, Ingo ^a   Wieland, Ulrike ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIF PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; STOP CODON; VIRION; VIRUS RECOMBINANT;

EID: 0030011040     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-7-1389     Document Type: Article

References (22)

1. Bairoch, A. (1992). PROSITE: a dictionary of sites and patterns in proteins. Nucleic Acids Research 20, 2013-2018.
2. Borman, A. M., Quillent, C., Charneau, P., Dauguet, C. & Clavel, F. (1995). Human immunodeficiency virus type 1 vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. Journal of Virology, 69, 2058-2067.
3. Bosch, V. & Pawlita, M. (1990). Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. Journal of Virology, 64, 2337-2344.
4. Courcoul, M., Patience, C., Rey, F., Blanc, D., Harmache, A., Sire, J., Vigne, R. & Spire, B. (1995). Peripheral blood mononuclear cells produce normal amounts of defective vif-human immunodeficiency virus type 1 particles which are restricted for the preretrotranscriptional steps. Journal of Virology 69, 2086-2074.
5. Freed, E. & Martin, M. A. (1994). HIV-1 infection in non-dividing cells. Nature 369, 107-108.
6. Gabuzda, D. H., Li, H., Lawrence, K., Vasir, B. S., Crawford, K. & Langhoff, E. (1994). Essential role of vif in establishing productive HIV-1 infections in peripheral blood T lymphocytes and monocytes/ macrophages. Journal of Acquired Immune Deficiency Syndromes 7,908-915.
7. Garret, E. D., Tiley, L. S. & Cullen, B. R. (1991). Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. Journal of Virology 65, 1653-1657.
8. Goncalves, J., Jallepalli, P. & Gabuzda, D. H. (1994). Subcellular localization of the Vif protein of human immunodeficiency virus type 1. Journal of Virology 68, 704-712.
9. Goncalves, J., Shi, B., Yang, X. & Gabuzda, D. (1995). Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. Journal of Virology 69, 7196-7204.
10. Kawamura, M., Ishizaki, T., Ishimoto, A., Shioda, T., Kitamura, T. & Adachi, A. (1994). Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. Journal of General Virology 75, 2427-2431.
11. Lindner, D., Geschwendt, M. & Marks, F. (1992). Phorbol ester-induced down-regulation of the 80-kD myristoylated alanine-rich C-kinase substrate related protein in Swiss 3T3 fibroblasts. Journal of Biological Chemistry 267, 24-26.
12. Michaels, F. H., Hattori, N., Gallo, R. C. & Franchini, G. (1993). The human immunodeficiency virus type 1 (HIV-1) Vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Research and Human Retroviruses 9, 1025-1030.
13. Myers, G., Wain-Hobson, S., Henderson, L. E., Korber, B., Jeang, K.-T. & Pavlakis, G. N. (Editors). (1994). Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico.
14. Perno, C.-F. & Yarchoan, R. (1991). Culture of HIV in monocytes and macrophages. In Current Protocols in Immunology, vol. 2, unit 12.4.3-12.4.4. Edited by J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach & W. Strobber. New York: John Wiley.
15. Poli, G. & Fauci, A. S. (1991). Isolation and quantitation of HIV in peripheral blood. In Current Protocols in Immunology, vol. 2, unit 12.2.2. Edited by J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach & W. Strobber. New York: John Wiley.
16. Sczakiel, G., Oelze, I. & Rittner, K. (1993). Microinjection: a technique to study inhibition of HIV-1 replication mediated by antisense RNA and parvovirus genes. In Biotechnology Applications of Microinjection, Microscopic Imaging, and Fluorescence, pp 1-10. Edited by P. Bach, C. H. Reynolds, J. M. Clark, P. Poole & J. Mottley. New York: Plenum Press.
17. Sova, P., Van Ranst, M., Gupta, P., Balachandran, R., Chao, W., Itescu, S., McKinley, G. & Volsky, D. J. (1995). Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. Journal of Virology 69, 2557-2564.
18. Subbramanian, R. A. & Cohen, E. A. (1994). Molecular biology of the human immunodeficiency virus accessory proteins. Journal of Virology 68, 6831-6835.
19. Wieland, U., Kratschmann, H., Kehm, R., Kühn, J. E., Näher, H., Kramer, M. D. & Braun, R. W. (1991). Antigenic domains of the HIV-1 Vif protein as recognized by human sera and murine monoclonal antibodies. AIDS Research and Human Retroviruses 7, 861-867.
20. Wieland, U., Hartmann, J., Suhr, H., Salzberger, B., Eggers, H. J. & Kühn, J. E. (1994). In vivo genetic variability of the HIV-1 vif gene. Virology 203, 43-51.
21. Wilk, T., Pfeiffer, T. & Bosch, V. (1992). Retained in vitro infectivity and cytopathicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189, 167-177.
22. Willey, R. L., Maldarelli, F., Martin, M. A. & Strebel, K. (1992). Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology 66, 7193-7200.